Research ArticleArticle
Open Access
Oligoarticular vs Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics
Dafna D. Gladman, Justine Y. Ye, Vinod Chandran, Ker-Ai Lee and Richard J. Cook
The Journal of Rheumatology August 2021, jrheum.210434; DOI: https://doi.org/10.3899/jrheum.210434
Dafna D. Gladman
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. VC was supported by a Pfizer Chair Rheumatology Research Award from the Department of Medicine, University of Toronto. D.D. Gladman, MD, FRCPC, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, and Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; J.Y. Ye, MS, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; V. Chandran, MBBS, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto; K.A. Lee, MMath, R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. D.D. Gladman, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Schroeder Arthritis Institute, 399 Bathurst St., Toronto, ON M5T 2S8, Canada. Email: dafna.gladman@utoronto.ca. Accepted for publication July 14, 2021.
Justine Y. Ye
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. VC was supported by a Pfizer Chair Rheumatology Research Award from the Department of Medicine, University of Toronto. D.D. Gladman, MD, FRCPC, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, and Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; J.Y. Ye, MS, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; V. Chandran, MBBS, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto; K.A. Lee, MMath, R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. D.D. Gladman, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Schroeder Arthritis Institute, 399 Bathurst St., Toronto, ON M5T 2S8, Canada. Email: dafna.gladman@utoronto.ca. Accepted for publication July 14, 2021.
Vinod Chandran
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. VC was supported by a Pfizer Chair Rheumatology Research Award from the Department of Medicine, University of Toronto. D.D. Gladman, MD, FRCPC, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, and Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; J.Y. Ye, MS, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; V. Chandran, MBBS, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto; K.A. Lee, MMath, R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. D.D. Gladman, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Schroeder Arthritis Institute, 399 Bathurst St., Toronto, ON M5T 2S8, Canada. Email: dafna.gladman@utoronto.ca. Accepted for publication July 14, 2021.
Ker-Ai Lee
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. VC was supported by a Pfizer Chair Rheumatology Research Award from the Department of Medicine, University of Toronto. D.D. Gladman, MD, FRCPC, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, and Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; J.Y. Ye, MS, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; V. Chandran, MBBS, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto; K.A. Lee, MMath, R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. D.D. Gladman, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Schroeder Arthritis Institute, 399 Bathurst St., Toronto, ON M5T 2S8, Canada. Email: dafna.gladman@utoronto.ca. Accepted for publication July 14, 2021.
Richard J. Cook
The University of Toronto Psoriatic Arthritis Program is supported by a grant from the Krembil Foundation. VC was supported by a Pfizer Chair Rheumatology Research Award from the Department of Medicine, University of Toronto. D.D. Gladman, MD, FRCPC, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, and Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; J.Y. Ye, MS, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto; V. Chandran, MBBS, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Institute of Medical Science, University of Toronto, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto; K.A. Lee, MMath, R.J. Cook, PhD, Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. The authors declare no conflict of interest relevant to this article. Address correspondence to Dr. D.D. Gladman, Director, Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, University Health Network, Toronto Western Hospital, Schroeder Arthritis Institute, 399 Bathurst St., Toronto, ON M5T 2S8, Canada. Email: dafna.gladman@utoronto.ca. Accepted for publication July 14, 2021.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Oligoarticular vs Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics
Dafna D. Gladman, Justine Y. Ye, Vinod Chandran, Ker-Ai Lee, Richard J. Cook
The Journal of Rheumatology Aug 2021, jrheum.210434; DOI: 10.3899/jrheum.210434